October 29, 2024,Hanoi, Vietnam : FPT Software, a leading global technology company, has been listed for the first time in the Gartner® Market Guide for Microsoft 365 Implementation and Support Services.
According to Gartner, “Microsoft 365’s productivity suite (Office, Outlook, Teams, SharePoint, OneDrive, etc.) optimizes productivity through collaboration and communications. Sourcing, procurement and vendor management leaders should use this guide to select service providers who can deliver business productivity goals.” In Gartner’s view, FPT Software’s recognition as one of 13 global Representative Vendors solidifies its standing as a trusted partner providing Microsoft 365 consulting, implementations, optimization, and managed services.
Frank Bignone, Global Director of FPT Software’s Digital Transformation (DX) Division, said: “At FPT Software, our key focus for the Microsoft 365 suite is developing Enterprise Copilot to empower businesses in streamlining their operations and reducing the burden of manual, time-consuming tasks. We believe this recognition positions us well to guide our clients through this journey, offering tailored services that ensure successful adoption, governance, and optimization of Microsoft 365, ultimately driving better business outcomes and agility in a rapidly evolving digital landscape.”
Gartner, Market Guide for Microsoft 365 Implementation and Support Services, Biswajit Maity, Mark Ray, Matt Baldino, Tom Sieber, 16 September 2024.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.